Research ArticleRheumatoid Arthritis
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset
Peter Youssef, Bruno Marcal, Peter Button, Matt Truman, Paul Bird, Hedley Griffiths, Lynden Roberts, Kathleen Tymms and Geoff Littlejohn
The Journal of Rheumatology August 2020, 47 (8) 1174-1181; DOI: https://doi.org/10.3899/jrheum.190535
Peter Youssef
From the Royal Prince Alfred Hospital, Camperdown; University of Sydney, Sydney; Roche Products Pty Ltd., Sydney; OzBiostat Pty Ltd., Sydney; University of New South Wales, Sydney; Barwon Rheumatology Service, Geelong; Monash Rheumatology, Clayton; Canberra Rheumatology, Canberra; Monash University, Clayton,
Australia.
Bruno Marcal
Peter Button
Matt Truman
Paul Bird
Hedley Griffiths
Lynden Roberts
Kathleen Tymms
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Australian Government
- 4.↵
- Favalli EG,
- Bugatti S,
- Biggioggero M,
- Caporali R
- 5.↵
- Singh JA,
- Saag KG,
- Bridges SL Jr,
- Akl EA,
- Bannuru RR,
- Sullivan MC,
- et al.
- 6.↵
- Smolen JS,
- Landewé R,
- Bijlsma J,
- Burmester G,
- Chatzidionysiou K,
- Dougados M,
- et al.
- 7.↵
- 8.↵
- Oldroyd AGS,
- Symmons DPM,
- Sergeant JC,
- Kearsley-Fleet L,
- Watson K,
- Lunt M,
- et al.
- 9.↵
- Roberts L,
- Tymms K,
- de Jager J,
- Littlejohn G,
- Griffiths H,
- Nicholls D,
- et al.
- 10.↵
- 11.↵
- Tymms K,
- Littlejohn G,
- Griffiths H,
- de Jager J,
- Bird P,
- Joshua F,
- et al.
- 12.↵Australian Government Department of Human Services. Arthritis -rheumatoid arthritis. [Internet. Accessed May 28, 2020.] Available from: www.humanservices.gov.au/health-professionals/enablers/rheumatoid-arthritis
- 13.↵
- Lipsky PE,
- van der Heijde DM,
- St Clair EW,
- Furst DE,
- Breedveld FC,
- Kalden JR,
- et al.
- 14.↵
- Weinblatt ME,
- Keystone EC,
- Furst DE,
- Moreland LW,
- Weisman MH,
- Birbara CA,
- et al.
- 15.↵
- 16.↵
- Finckh A,
- Simard JF,
- Gabay C,
- Guerne PA;
- SCQM physicians
- 17.↵
- Choquette D,
- Bessette L,
- Haraoui B,
- Massicotte F,
- Pelletier JP,
- Raynauld JP,
- et al.
- 18.↵
- Favalli EG,
- Sinigaglia L,
- Becciolini A,
- Grosso V,
- Gorla R,
- Bazzani C,
- et al.
- 19.↵
- 20.↵
- Soubrier M,
- Pereira B,
- Frayssac T,
- Fan A,
- Couderc M,
- Malochet-Guinamand S,
- et al.
- 21.↵
- Gorman A,
- Cowley S,
- Camon A,
- Osman I,
- Khan S,
- Mohammad A,
- et al.
- 22.↵
- Movahedi M,
- Couta S,
- Cesta A,
- Bombardier C
- 23.↵
- Elkin E,
- Bergman MJ,
- Kamath T,
- Ogale S,
- Turpcu A,
- King K,
- et al.
- 24.↵
- Gottenberg JE,
- Brocq O,
- Perdriger A,
- Lassoued S,
- Berthelot JM,
- Wendling D,
- et al.
- 25.↵
- Rotar Z,
- Hocevar A,
- Rebolj Kodre A,
- Praprotnik S,
- Tomsic M,
- Slovenian R
- 26.↵
- Gottenberg JE,
- Morel J,
- Perrodeau E,
- Bardin T,
- Combe B,
- Dougados M,
- et al;
- French Society of Rheumatology and the investigators participating in AIR ORA, and REGATE registries
- 27.↵
- Lauper K,
- Nordstrom DC,
- Pavelka K,
- Hernandez MV,
- Kvien TK,
- Kristianslund EK,
- et al.
- 28.↵
- 29.↵
- Emery P,
- Gottenberg JE,
- Rubbert-Roth A,
- Sarzi-Puttini P,
- Choquette D,
- Taboada VM,
- et al.
- 30.↵
- Finckh A,
- Ciurea A,
- Brulhart L,
- Kyburz D,
- Moller B,
- Dehler S,
- et al;
- Swiss Clinical Quality Management Program for Rheumatoid Arthritis
In this issue
The Journal of Rheumatology
Vol. 47, Issue 8
1 Aug 2020
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset
Peter Youssef, Bruno Marcal, Peter Button, Matt Truman, Paul Bird, Hedley Griffiths, Lynden Roberts, Kathleen Tymms, Geoff Littlejohn
The Journal of Rheumatology Aug 2020, 47 (8) 1174-1181; DOI: 10.3899/jrheum.190535
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset
Peter Youssef, Bruno Marcal, Peter Button, Matt Truman, Paul Bird, Hedley Griffiths, Lynden Roberts, Kathleen Tymms, Geoff Littlejohn
The Journal of Rheumatology Aug 2020, 47 (8) 1174-1181; DOI: 10.3899/jrheum.190535